Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2504-2509
Published online before print September 14, 2006, doi: 10.1161/01.ATV.0000245796.97133.ad
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/11/2504    most recent
01.ATV.0000245796.97133.adv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hakala, J. K.
Right arrow Articles by Pentikäinen, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hakala, J. K.
Right arrow Articles by Pentikäinen, M. O.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2504.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Low-Density Lipoprotein Modified by Macrophage-Derived Lysosomal Hydrolases Induces Expression and Secretion of IL-8 Via p38 MAPK and NF-{kappa}B by Human Monocyte-Derived Macrophages

Jukka K. Hakala; Ken A. Lindstedt; Petri T. Kovanen; Markku O. Pentikäinen

From Wihuri Research Institute, Helsinki, Finland.

Correspondence to Petri T. Kovanen, Wihuri Research Institute, Kalliolinnantie 4, FIN-00140 Helsinki, Finland. E-mail Petri.Kovanen{at}wri.fi

Objective— Modified lipoproteins induce inflammatory reactions in the atherosclerotic arterial wall. We have previously found that macrophages in atherosclerotic lesions secrete lysosomal hydrolases that can modify low-density-lipoprotein (LDL) in vitro to generate "hydrolase-modified LDL" (H-LDL). Here, we studied whether H-LDL exerts inflammatory effects on cultured human macrophages.

Methods and Results— Using cytokine cDNA arrays, we found that H-LDL induced expression of IL-8, but not of the anti-inflammatory cytokines IL-10 and transforming growth factor (TGF)-ß, in human monocyte-derived macrophages. H-LDL induced rapid phosphorylation of the p38 mitogen-activated protein kinase (MAPK), nuclear translocation of 2 transcription factors, nuclear factor {kappa}B (NF-{kappa}B) and activator protein 1 (AP-1), and time-dependent secretion of IL-8 from the macrophages. Inhibition of MAPKs and of transcription factors showed that p38 MAPK and NF-{kappa}B, but not ERK1/2, JNK, or AP-1, were crucial for the H-LDL–induced IL-8 secretion from the macrophages.

Conclusions— The results show that by activating p38 MAPK and NF-{kappa}B, macrophage hydrolases modify LDL into biologically active particles capable of triggering the secretion of IL-8 in macrophages. Thus, activated hydrolase-secreting macrophages in atherosclerotic lesions may sustain a proatherogenic extracellular environment by hydrolyzing LDL and triggering it to act in an autocrine or paracrine fashion to induce IL-8 secretion by the plaque macrophages.

LDL modified by secreted macrophage-derived lysosomal hydrolases (H-LDL) induce secretion of IL-8 by cultured human monocyte-derived macrophages. Secretion of IL-8 by H-LDL–stimulated macrophages depended on the activation of p38 MAPK and NF-{kappa}B transcription factor.


Key Words: atherosclerosis • cytokines • inflammation • LDL